QLY Biotech Group Corp. Quarterly Liabilities in USD from Q3 2019 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
Summary
QLY Biotech Group Corp. quarterly Liabilities history and growth rate from Q3 2019 to Q1 2023.
  • QLY Biotech Group Corp. Liabilities for the quarter ending February 28, 2023 was $19.7K, a 38.6% increase year-over-year.
Liabilities, Quarterly (USD)
Liabilities, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 $19.7K +$5.48K +38.6% Feb 28, 2023 10-Q 2023-04-13
Q4 2022 $8.05K -$4.85K -37.6% Nov 30, 2022 10-Q 2023-01-13
Q3 2022 $0 -$13.1K -100% Aug 31, 2022 10-Q 2023-04-13
Q2 2022 $17.1K -$4.49K -20.8% May 31, 2022 10-Q 2022-06-13
Q1 2022 $14.2K -$5.61K -28.3% Feb 28, 2022 10-Q 2022-04-07
Q4 2021 $12.9K +$5.1K +65.4% Nov 30, 2021 10-Q 2021-12-13
Q3 2021 $13.1K +$5.33K +68.3% Aug 31, 2021 10-K 2022-12-14
Q2 2021 $21.6K +$13.8K +177% May 31, 2021 10-Q 2021-07-09
Q1 2021 $19.8K +$12K +154% Feb 28, 2021 10-Q/A 2021-06-01
Q4 2020 $7.8K Nov 30, 2020 10-Q 2020-12-31
Q3 2020 $7.8K +$4.82K +162% Aug 31, 2020 10-K 2021-11-22
Q2 2020 $7.8K May 31, 2020 10-Q 2020-07-15
Q1 2020 $7.8K Feb 29, 2020 10-Q 2020-04-09
Q3 2019 $2.98K Aug 31, 2019 10-K 2020-10-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.